Expression of Angiogenesis-Related Genes in the Cellular Component of the Blood of Preeclamptic Women

Reproductive Sciences

Volumn 16, Issue 9, 2009, Pages 857-864

  Purwosunu, Yuditiya ^a   Sekizawa, Akihiko ^b   Yoshimura, Shiho ^b   Wibowo, Noroyono ^b   Nakamura, Masamitsu ^b   Shimizu, Hanako ^b   Okai, Takashi ^b   Farina, Antonio ^c  

^a CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

cellular RNA; endoglin; Flt 1; maternal blood; Preeclampsia

Indexed keywords

BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; FLT1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MESSENGER RNA; PLACENTA PROTEIN; PRODUCT PLACENTA GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VEGFA PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CYTOLOGY; FEMALE; GENE EXPRESSION; GENETICS; HELLP SYNDROME; HOSPITALIZATION; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; PREECLAMPSIA; PREGNANCY; THROMBOCYTE; TROPHOBLAST;

ADOLESCENT; ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; BLOOD PLATELETS; FEMALE; GENE EXPRESSION; HELLP SYNDROME; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 70350704487     PISSN: 19337191     EISSN: None     Source Type: Journal    
DOI: 10.1177/1933719109336622     Document Type: Article

References (27)

1. Redman C.W., Sargent I.L. Latest advances in understanding preeclampsia. Science. 2005; 308 (5728): 1592 - 1594.
2. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet. 2005; 365 (9461): 785 - 799.
3. Levine R.J., Lam C., Qian C., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006; 355 (10): 992 - 1005.
4. Levine R.J., Maynard S.E., Qian C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004; 350 (7): 672 - 683.
5. Venkatesha S., Toporsian M., Lam C., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006 ; 12 (6): 642 - 649.
6. Gerber H.P., Hillan K.J., Ryan A.M., et al. VEGF is required for growth and survival in neonatal mice. Development. 1999; 126 (6): 1149 - 1159.
7. Clark D.E., Smith S.K., Sharkey A.M., Charnock-Jones D.S. Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. Hum Reprod. 1996; 11 (5): 1090 - 1098.
8. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol. 2001 ; 280 (6): C1358 - C1366.
9. He H., Venema V.J., Gu X., Venema R.C., Marrero M.B., Caldwell R.B. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem. 1999; 274 (35): 25130 - 25135.
10. He Y., Smith S.K., Day K.A., Clark D.E., Licence D.R., Charnock-Jones D.S. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol. 1999; 13 (4): 537 - 545.
11. Yang J.C., Haworth L., Sherry R.M., et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med. 2003; 349 (5): 427 - 434.
12. Maynard S.E., Min J.Y., Merchan J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003; 111 (5): 649 - 658.
13. Gougos A., St Jacques S., Greaves A., et al. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol. 1992; 4 (1): 83 - 92.
14. St-Jacques S., Forte M., Lye S.J., Letarte M. Localization of endoglin, a transforming growth factor-beta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod. 1994; 51 (3): 405 - 413.
15. Sanchez-Elsner T., Botella L.M., Velasco B., Langa C., Bernabeu C. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem. 2002; 277 (46): 43799 - 43808.
16. Bourdeau A., Dumont D.J., Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest. 1999; 104 (10): 1343 - 1351.
17. Toporsian M., Gros R., Kabir M.G., et al. A rolefor endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res. 2005; 96 (6): 684 - 692.
18. Purwosunu Y., Sekizawa A., Farina A., et al. Evaluation of physiological alterations of the placenta through analysis of cell-free mRNA concentrations of angiogenic factors. Am J Obstet Gynecol. 2007 IN PRESS.
19. Purwosunu Y., Sekizawa A., Koide K., et al. Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia. Clin Chem. 2007; 53 (3): 399 - 404.
20. Purwosunu Y., Sekizawa A., Farina A., et al. Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. Prenat Diagn. 2007; 27 (8): 772 - 777.
21. Okazaki S., Sekizawa A., Purwosunu Y., Iwasaki M., Farina A., Okai T. Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal blood. J Med Genet. 2006; 43 (9): e47.
22. Okazaki S., Sekizawa A., Purwosunu Y., Farina A., Wibowo N., Okai T. Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women. Obstet Gynecol. 2007 ; 110 (5): 1130 - 1136.
23. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002; 77 (1): 67 - 75.
24. Farina A., Sekizawa A., Purwosunu Y., et al. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. Prenat Diagn. 2006; 26 (12): 1115 - 1120.
25. Obiekwe B.C., Sturdee D., Cockrill B.L., Chard T. Human placental lactogen in pre-eclampsia. Br J Obstet Gynaecol. 1984; 91 (11): 1077 - 1080.
26. Shore V.H., Wang T.H., Wang C.L., Torry R.J., Caudle M.R., Torry D.S. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta. 1997 ; 18 (8): 657 - 665.
27. Taylor R.N., Grimwood J., Taylor R.S., McMaster M.T., Fisher S.J., North R.A. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol. 2003; 188 (1): 177 - 182.